Cowen and Company’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Cowen and Company’s Portfolio CHAQ.WS Stock Details CHAQ.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,000	Closed	-$13K	–	857
2021 Q2	$13K	Sell	20,000 -1,977	-9%	-$1.42K	﹤0.01%	529
2021 Q1	$21K	Buy	+21,977	New	+$24.3K	﹤0.01%	451

Cowen and Company's CHAQ.WS Position: Q3 2021 in Review

Cowen and Company sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 20,000 shares — an estimated $13K sold.

Cowen and Company first reported a position in CHAQ.WS in Q1 2021 and held it in 2 quarters. The position peaked at $21K in Q1 2021. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.

Cowen and Company reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
Cowen and Company sold 20,000 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $13K.
Cowen and Company first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q1 2021 and held it in 2 quarters.
Cowen and Company's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $21K in Q1 2021.
0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.

Based on Cowen and Company's 13F filing for Q3 2021, filed 12 Nov 2021.